Immunotherapy Explained Part 1. Danny and I break down immunotherapy in this 3 part series. In part 1, we discuss an overview of the basic biology behind immunotherapy. Video is around 1 hour long. We talk about the various approaches…
Tag: stock
Biotech and StockMarket Podcast May 31 2016
Biotech and StockMarket Podcast May 31 2016… $IONS $RLYP Gold, Oil + Macros $IONs discussed here on why we took call options. Danny explains the situation there and why it’s not as bad as the market is thinking. We also…
Free Public Preview Video: Explanation on Current Market Situation Jan.29, 2014
Explanation on Current Market Situation Jan.29, 2014. $SPY reviewed later on in video. Mis-speak, I said “76 Million jobs” I later correct that to the proper “76 thousand jobs” I speak about potential head and shoulders in the charts, as…
BioPharma Catalyst And Investment Pick In Focus Synergy Pharma
Today at stockmatusow, we focus on a Bio-Pharmaceutical company with several near-term catalysts and give our thesis why we believe the company makes for a good long term speculative investment. Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to…
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
Important Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Bullish Free Articles Bullish Premium Articles Commentary Free Articles Commentary Premium Articles Free Articles Premium Articles
Edited: Is An Acquisition Of Solta Medical Imminent?
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments. However, I do feel the company and its…
Video: Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
$HALO 1132 Sept calls bought at 7.50 strike.
$HALO just had 1132 Sept calls bought at 7.50 strike, someone knows something, therefore, I bought shares, looking for Monday Potential Gap. I’ve been buying, average about $7.60 or so. CHMP decision expected in Europe,. With that many calls taken…
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
